Journal
AIDS AND BEHAVIOR
Volume 10, Issue 5, Pages 483-493Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10461-006-9106-6
Keywords
HIV; antiretroviral; adherence; disclosure; social support
Funding
- NIMH NIH HHS [R01 MH61173, T32 MH19139, P30 MH043520] Funding Source: Medline
Ask authors/readers for more resources
This study examined the relationship between HIV serostatus disclosure and adherence to antiretroviral therapy (ART). The study was conducted with 215 HIV-seropositive patients who demonstrated poor adherence (< 80%) and who were in serodiscordant relationships. Participants completed self-report measures regarding HIV serostatus disclosure and reasons for missing ART doses, as well as electronic monitoring of ART adherence (MEMS caps). Overall, 19% of the sample reported missing medication doses in the last two months due to concerns regarding serostatus disclosure. Participants who reported greater serostatus disclosure to others demonstrated higher rates of adherence, and this relationship remained after controlling for other explanatory variables. The relationship between disclosure and adherence was not mediated by practical support for adherence from others. Interventions to improve ART adherence should address the role of serostatus disclosure by providing patients with skills to maintain adherence in contexts of non-disclosure and to make informed choices regarding selective disclosure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available